Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

There have been 49 recent insider transactions recorded for Vallon Pharmaceuticals, Inc. (VLON), including 30 buys and 8 sells. Total insider buying was valued at $3M and total insider selling at $254.48K.

Notable insiders with recent activity include Kelly Leanne, Szekeres David Leslie, Rongen Roelof. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — VLON

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2023-09-22	Kelly Leanne	Chief Financial Officer	RSU Award	83,333	$1.52	$126.67K	83,333
2023-08-10	Szekeres David Leslie	Director	RSU Award	34,483	$2.90	$100K	34,483
2023-08-10	Rongen Roelof	Director	RSU Award	34,483	$2.90	$100K	34,483
2023-08-10	Simpson Camilla V	Director	RSU Award	34,483	$2.90	$100K	34,483
2023-08-10	Baker David Charles	Director	RSU Award	34,483	$2.90	$100K	34,483
2023-04-21	Szekeres David Leslie	Director	Unknown	-	-	-	-
2023-04-21	Agro Albert	Chief Medical Officer	RSU Award	172,189	-	-	172,189
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	RSU Award	385,510	-	-	385,510
2023-04-21	Chaturvedi Vipin	Chief Scientific Officer	RSU Award	172,189	-	-	172,189
2023-04-21	Agro Albert	Officer	Unknown	-	-	-	-
2023-04-21	Rongen Roelof	Director	Unknown	-	-	-	-
2023-04-21	Simpson Camilla V	Director	Unknown	-	-	-	-
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	Unknown	-	-	-	-
2023-04-21	Chaturvedi Vipin	Officer	Unknown	-	-	-	-
2022-12-13	Thorell Marella	Director	Other (Sell)	28,517	-	-	9,506
2022-07-01	Thorell Marella	Director	RSU Award	38,023	-	-	38,023
2022-06-09	Payne Joseph E	Director	RSU Award	7,500	-	-	7,500
2022-06-09	Thorell Marella	Director	RSU Award	7,500	$0.51	$3.83K	7,500
2022-06-09	Ammer Richard	Director	RSU Award	7,500	-	-	7,500
2022-02-23	Chhabra Meenu	Director	Unknown	-	-	-	-
2022-02-23	Chhabra Meenu	Director	RSU Award	15,000	$7.67	$115.05K	15,000
2022-02-15	Kelly Leanne M.	Chief Financial Officer	RSU Award	50,000	$5.63	$281.5K	50,000
2022-02-15	Baker David Charles	Chief Executive Officer	RSU Award	61,000	$5.63	$343.43K	61,000
2021-06-04	Kelly Leanne M.	Chief Financial Officer	Informative Buy	1,508	$4.08	$6.15K	6,250
2021-06-03	Kelly Leanne M.	Chief Financial Officer	Informative Buy	1,085	$4.05	$4.39K	4,742
2021-06-02	Kelly Leanne M.	Chief Financial Officer	Informative Buy	3,657	$4.00	$14.63K	3,657
2021-05-26	Payne Joseph E	Director	Informative Buy	6,800	$4.50	$30.6K	17,500
2021-05-25	Payne Joseph E	Director	Informative Buy	10,700	$3.85	$41.2K	10,700
2021-05-14	Kelly Leanne M.	Chief Financial Officer	RSU Award	70,000	$3.66	$256.2K	70,000
2021-05-14	Payne Joseph E	Director	RSU Award	14,286	$3.66	$52.29K	14,286
2021-05-14	Toren Penny	SVP, Regul Affairs & Prog Mgmt	RSU Award	25,000	$3.66	$91.5K	25,000
2021-05-14	Levi Ofir	Director	RSU Award	15,000	$3.66	$54.9K	15,000
2021-05-14	Ammer Richard	Director	RSU Award	10,204	$3.66	$37.35K	10,204
2021-05-14	Baker David Charles	Chief Executive Officer	RSU Award	100,000	$3.66	$366K	100,000
2021-05-11	Kelly Leanne M.	Officer	Unknown	-	-	-	-
2021-02-12	Thorell Marella	Director	RSU Award	15,000	$8.00	$120K	15,000
2021-02-12	Ammer Richard	Director	Other (Buy)	47,063	$6.40	$301.2K	47,063
2021-02-12	Salmon Pharma Gmbh	10 Percent Owner	Other (Buy)	47,063	$6.40	$301.2K	47,063
2021-02-12	Baker David Charles	Chief Executive Officer	Other (Buy)	7,843	$6.40	$50.2K	7,843
2021-02-09	Thorell Marella	Director	Unknown	-	-	-	-
2021-02-09	Toren Penny	SVP, Regul Affairs & Prog Mgmt	Disposition	5,000	$3.82	$19.1K	-
2021-02-09	Levi Ofir	Director	Disposition	-	-	-	196,875
2021-02-09	Ammer Richard	10 Percent Owner	Unknown	-	-	-	1,476,734
2021-02-09	Salmon Pharma Gmbh	10 Percent Owner	Disposition	-	-	-	1,476,734
2021-02-09	Payne Joseph E	10 Percent Owner	Unknown	-	-	-	843,750
2021-02-09	Arcturus Therapeutics Holdings Inc.	10 Percent Owner	Disposition	-	-	-	843,750
2021-02-04	Baker David Charles	Chief Executive Officer	Disposition	61,250	$2.20	$134.75K	-
2019-01-15	Baker David Charles	Chief Executive Officer	Disposition	46,875	$1.84	$86.25K	-
2018-10-01	Toren Penny	SVP, Regul Affairs & Prog Mgmt	Disposition	7,813	$1.84	$14.38K	-

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry